Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
City of Hope Medical Center
NeoImmuneTech
AstraZeneca
I-Mab Biopharma US Limited
Sotio Biotech Inc.
Shasqi, Inc.
Alaunos Therapeutics
Incyte Corporation
Elicio Therapeutics
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
Institut Bergonié
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
University of Pennsylvania
NextCure, Inc.
National Institutes of Health Clinical Center (CC)
Elevation Oncology
Stanford University
Deciphera Pharmaceuticals, LLC
BeiGene
Sellas Life Sciences Group
Mundipharma Research Limited
Rain Oncology Inc
NantCell, Inc.
NantCell, Inc.
Pfizer
ADC Therapeutics S.A.
Cancer Research and Biostatistics Clinical Trials Consortium
Exelixis
Pfizer
Tesaro, Inc.
Memorial Sloan Kettering Cancer Center
Pfizer
CytomX Therapeutics
pharmaand GmbH
Canadian Cancer Trials Group
Hoffmann-La Roche
Genmab
OncoNano Medicine, Inc.
Revolution Medicines, Inc.
Herlev Hospital
Incyte Corporation
Duke University
Five Prime Therapeutics, Inc.
Incyte Corporation